Aimia (AIM) Q3 2024 earnings summary

Executive summary

• Achieved consolidated revenue of $129.1M in Q3 2024, up 13% year-over-year, with strong performance from core holdings Bozzetto and Cortland despite macroeconomic and logistical headwinds.

• Adjusted EBITDA rose 55% to $15.0M, driven by cost reductions, operational improvements, and the StarChem acquisition.

• Net loss narrowed to $1.9M, including $2M in settlement expenses and $2.4M in tax expense.

• Settlement and cooperation agreement with largest shareholder Mithaq, resulting in board expansion, litigation dismissal, and standstill provisions through March 2026.

• Strategic Review Committee formed to explore options for optimizing capital structure, monetizing non-core assets, and maximizing value from core holdings.

Financial highlights

• Q3 2024 revenue was $129.1M, up from $114.3M in Q3 2023; gross profit rose to $35.4M from $22.9M, with gross margin improving to 27.4% from 20.0% year-over-year.

• Adjusted EBITDA increased to $15.0M from $9.7M; net loss narrowed to $(1.9)M from $(34.4)M.

• EPS improved to $(0.07) from $(0.45) year-over-year.

• Cash and marketable securities at $121.4M as of September 30, 2024, up from $114.6M in the previous quarter.

• Paid $3.9M in preferred share dividends; quarterly dividend payments increased by $600,000 starting Q2 2024.

Outlook and guidance

• On track to meet full-year guidance for combined Adjusted EBITDA of $80–$85M for Bozzetto and Cortland, at the lower end of the range.

• Corporate operating costs for 2024 anticipated at approximately $13M, excluding one-time expenses.

• Expects cash position to decline in Q4 due to Bozzetto loan repayments; cost management and liquidity preservation are priorities.